GlassScriptPhysician profile
Eduardo Balcells
NPI 1649206582
$1,318.48
in general payments reported to CMS, 2019-2025
16 companies · $156 in 2025
The $156 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $555 · 2020: $466 · 2021: $33.62 · 2022: $11.70 · 2023: $14.54 · 2024: $81.81 · 2025: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $253.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $252.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $279.91 | 2019-2025 | Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $189.30 | 2019-2025 | Lifevest |
| Pfizer INC. | $146.13 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $102.91 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $87.24 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $76.14 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $75.48 | 2019-2020 | |
| Livanova USA, INC. | $69.77 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $63.52 | 2019-2025 | Camzyos |
| Amarin Pharma, INC. | $62.64 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $59.07 | 2019 | |
| Medtronic, INC. | $33.42 | 2025 | Linq II |
| Abbott Laboratories | $23.65 | 2024 | Optis |
| Terumo Medical Corporation | $20.04 | 2025 | Tr Band |
| Regeneron Healthcare Solutions, INC. | $15.60 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $13.66 | 2024 | Lux-Dx Insertable Cardiac Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eduardo Balcells listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.